Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MIH Climate Impact Capital is a venture investment institution focused on supporting innovation in climate technology and sustainability. The firm invests globally, with particular emphasis on connecting Asian supply chains to global technologies. It acts as both investor and venture builder, helping portfolio companies scale production and accelerate go-to-market strategies. The group originated from Taiwan but has networks across Greater China, Southeast Asia, the US, and beyond.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MIH Climate Impact Capital.